Moderna Announces Coronavirus Vaccine With 95.5% Success Rate
Moderna Inc. claims that its COVID-19 vaccine is 94.5% effective—a higher rate than Pfizer’s vaccine.
- By Nikki Johnson-Bolden
- Nov 17, 2020
Biotech company Moderna Inc. announced on November 16 that the coronavirus vaccine it has developed is 94.5% effective, according to NPR.
This information arrives on the heels of a new record number of coronavirus cases. As of November 15, there are more than 11 million confirmed COVID-19 cases in the United States. Johns Hopkins’ COVID-19 tracker reports 166,55 new cases and 1,266 new deaths. This new peak occurs just six days after the U.S. reached 10 million coronavirus cases.
This is the second vaccine of nearly 100% effectiveness to emerge—last week, Pfizer announced its own vaccine with a 90% rate of effectiveness.
Moderna will file for emergency use authorization from the FDA for the vaccine within the next few weeks. The company expects to ship 20 million doses of the vaccine in the United States by the end of this year.
Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.